Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX1 | P07099 | 2/20 | 0.68 |
| ▸ | EPHX2 | P34913 | 8/20 | 0.67 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.55 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.55 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.53 |
| ▸ | GAA | P10253 | 1/20 | 0.53 |
| ▸ | LMNA | P02545 | 1/20 | 0.50 |
| ▸ | HTT | P42858 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19757636 | 1.00 | EPHX1 (0.68) | EPHX1EPHX2KMT2ASMN1; SMN2SIGMAR1 | |
| Methyl Alcohol SCHEMBL23645020 | 0.98 | EPHX1 (0.66) | EPHX1EPHX2KMT2ASMN1; SMN2SIGMAR1 | |
| SCHEMBL16037882 | 0.90 | — | — | |
| Perchlorate SCHEMBL10990424 | 0.90 | EPHX1 (0.58) | EPHX1EPHX2KMT2ASMN1; SMN2SIGMAR1 | |
| SCHEMBL6058547 | 0.86 | EPHX1 (0.53) | EPHX1EPHX2KMT2ASMN1; SMN2SIGMAR1 | |
| SCHEMBL13977177 | 0.84 | EPHX1 (0.51) | EPHX1EPHX2KMT2ASMN1; SMN2SIGMAR1 | |
| SCHEMBL17226608 | 0.84 | EPHX1 (0.51) | EPHX1EPHX2KMT2ASMN1; SMN2SIGMAR1 | |
| SCHEMBL1032460 | 0.84 | EPHX1 (0.51) | EPHX1EPHX2KMT2ASMN1; SMN2SIGMAR1 | |
| SCHEMBL1032166 | 0.84 | EPHX1 (0.51) | EPHX1EPHX2KMT2ASMN1; SMN2SIGMAR1 | |
| SCHEMBL30549313 | 0.84 | EPHX1 (0.51) | EPHX1EPHX2KMT2ASMN1; SMN2SIGMAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 506 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12469693-B2 | Method of forming a carbon-containing layer and structure including the layer | ASM IP HOLDING B.V. (NL) | 2025-11-11 | — | — | US | claimed |
| CN-112250594-B | Method for preparing 3-acetamido-1-adamantanol | 浙江荣耀生物科技股份有限公司 | 2023-09-12 | — | — | CN | claimed |
| CN-116217817-A | Seed emulsion for covering polymer and preparation method thereof | 万华化学集团股份有限公司 | 2023-06-06 | — | — | CN | claimed |
| CN-112939798-B | Preparation method of amantadine | 肯特催化材料股份有限公司 | 2022-07-19 | — | — | CN | claimed |
| CN-112939798-A | Preparation method of amantadine | 浙江理工大学 | 2021-06-11 | — | — | CN | claimed |
| CN-112853382-A | Electrochemical synthesis method of 1-acetamido adamantane | 北京工业大学 | 2021-05-28 | — | — | CN | claimed |
| US-20210082692-A1 | METHOD OF FORMING A CARBON-CONTAINING LAYER AND STRUCTURE INCLUDING THE LAYER | ASM IP HOLDING B.V. (NL) | 2021-03-18 | — | — | US | claimed |
| CN-112250594-A | Method for preparing 3-acetamido-1-adamantanol | 浙江荣耀生物科技股份有限公司 | 2021-01-22 | — | — | CN | claimed |
| US-10613435-B2 | Coating solution for resist pattern coating and method for forming pattern | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2020-04-07 | — | — | US | claimed |
| CN-109265357-A | A kind of synthetic method of amantadine hydrochloride | 赵旭萌 | 2019-01-25 | — | — | CN | claimed |
| US-20140295350-A1 | RESIST PATTERN-FORMING METHOD, AND RADIATION-SENSITIVE RESIN COMPOSITION | JSR CORP (JP) | 2014-10-02 | — | — | US | claimed |
| US-8481016-B2 | Method for inhibition of potential-dependent cation channel | KAO CORPORATION (JP) | 2013-07-09 | — | — | US | claimed |
| US-20130045177-A1 | Method for Inhibition of Potential-Dependent Cation Channel | KAO CORPORATION (JP) | 2013-02-21 | — | — | US | claimed |
| US-20120316143-A1 | Ophthalmic composition | SOLL DAVID B (US) | 2012-12-13 | — | — | US | claimed |
| EP-1989177-B1 | AMIDOADAMANTANES AND METHOD FOR PRODUCING THE SAME | UNIV GIESSEN JUSTUS LIEBIG (DE) | 2012-08-01 | — | — | EP | claimed |
| EP-1721888-B1 | Process for synthesising aminoadamantanes | A M S A ANONIMA MATERIE SINT E (IT) | 2010-05-05 | — | — | EP | claimed |
| US-20090299096-A1 | Amidoadamantanes and Method for Producing the Same | JUSTUS-LIEBIG-UNIVERSITAT GIESSEN (DE) | 2009-12-03 | — | — | US | claimed |
| EP-1989177-A1 | AMIDOADAMANTANES AND METHOD FOR PRODUCING THE SAME | Justus-Liebig-Universität Giessen (DE) | 2008-11-12 | — | — | EP | claimed |
| WO-2007101535-A1 | AMIDOADAMANTANES AND METHOD FOR PRODUCING THE SAME | JUSTUS-LIEBIG-UNIVERSITÄT GIESSEN (DE) | 2007-09-13 | — | — | WO | claimed |
| US-4894180-A | Liquid crystal optical element | FUJI PHOTO FILM CO., LTD. (JP) | 1990-01-16 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130045177-A1 | Method for Inhibition of Potential-Dependent Cation Channel | TRPM7, TRPM8, OR10J3 | EPHX1 974/4885EPHX2 1636/4885KMT2A 3964/4885 |
| US-20090299096-A1 | Amidoadamantanes and Method for Producing the Same | ADORA3, TAAR5, ADORA1 | EPHX1 3061/4885EPHX2 1578/4885KMT2A 2743/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.